Toggle Main Menu Toggle Search

Open Access padlockePrints

Risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications - reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study

Lookup NU author(s): Professor Chris LambORCiD, Dr Marcus Brookes, Dr Sesha Subramanian

Downloads


Licence

This is the authors' accepted manuscript of an article that has been published in its final definitive form by Wiley-Blackwell Publishing Ltd., 2021.

For re-use rights please refer to the publisher's terms and conditions.


Publication metadata

Author(s): Lamb CA, Sebastian S, Kent AJ, Segal JP, Gonzalez HA, Brookes MJ, Mehta SJ, Subramanian S, Bhala N, Hicks LC, Conley TE, Patel KV, Walker GJ, Kennedy NA

Publication type: Article

Publication status: Published

Journal: Alimentary Pharmacology & Therapeutics

Year: 2021

Volume: 53

Issue: 11

Pages: 1236-1240

Print publication date: 01/06/2021

Online publication date: 07/05/2021

Acceptance date: 11/03/2021

Date deposited: 11/03/2021

ISSN (print): 0269-2813

ISSN (electronic): 1365-2036

Publisher: Wiley-Blackwell Publishing Ltd.

URL: https://doi.org/10.1111/apt.16349

DOI: 10.1111/apt.16349


Altmetrics

Altmetrics provided by Altmetric


Share